Skip to main content
    S

    Stryker Corporation (SYK)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $310.67
    +1.03 (+0.33%)

    Market Cap: $117.88B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Stryker Corporation (SYK) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Stryker (SYK) to earn $14.83 per share in the fiscal year ending Dec 31, 2026, on revenue of $26.81B. Of 30 analysts, 22 rate the stock Buy or Strong Buy, 8 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $16.29.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 30 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 73% of the ratings.

    RatingAnalystsShare
    Strong Buy826.7%
    Buy1446.7%
    Hold826.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    30

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 9.8% and revenue estimates rise 7.1%.

    Fiscal year ending Dec 31, 2026
    $14.83
    EPS consensus, revenue $26.81B
    Fiscal year ending Dec 31, 2027
    $16.29
    EPS consensus, revenue $28.72B
    Next report
    Jan 27, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$14.83$14.80 to $14.8829$26.81B$26.70B to $26.90B27
    Dec 31, 2027$16.29$16.00 to $16.5129$28.72B$28.32B to $30.98B28

    Quarterly Estimates

    The EPS consensus falls from $5.06 for the quarter ending Dec 31, 2026 to $3.18 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$5.06$4.55 to $5.3028$7.76B$7.42B to $8.16B28
    Mar 31, 2027$3.18$2.83 to $3.6316$6.52B$6.41B to $6.68B14

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 29 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2027020
    Quarter ending Mar 31, 202719

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 1.3% from $15.02.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$14.83$14.83$14.97$15.01$15.02-1.2%
    Fiscal year ending Dec 31, 2027$16.29$16.31$16.70$16.74$16.76-2.8%
    Quarter ending Mar 31, 2027$3.18$3.18$3.28$3.29$3.30-3.7%

    Frequently Asked Questions About SYK

    What is the SYK stock forecast?

    Consensus analyst estimates put Stryker's EPS at $14.83 for the fiscal year ending Dec 31, 2026, on revenue of $26.81B. The consensus rating from 30 analysts is Buy.

    How do analysts rate SYK stock?

    Of 30 analysts covering Stryker, 8 rate it Strong Buy, 14 Buy, 8 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SYK next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $14.83, with estimates from $14.80 to $14.88 from 29 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $16.29, with estimates from $16.00 to $16.51 from 29 analysts.

    What revenue do analysts expect from Stryker next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $26.81B, with estimates from $26.70B to $26.90B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $28.72B, with estimates from $28.32B to $30.98B.

    How many analysts cover SYK?

    30 analysts rate Stryker stock, and 29 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.